- Home
- NAVI vs SANA Comparison
NAVI vs SANA Comparison
Compare NAVI & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAVI | SANA |
|---|---|---|
| Founded | 1973 | 2018 |
| Country | United States | United States |
| Employees | 670 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 760.4M | 793.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAVI | SANA |
|---|---|---|
| Price | $8.83 | $3.18 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $10.00 | $7.80 |
| AVG Volume (30 Days) | 765.9K | ★ 2.6M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.73% | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $76.23 | N/A |
| Revenue Next Year | $15.73 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.33 | $2.61 |
| 52 Week High | $13.87 | $6.55 |
Technical Indicators
Market Signals| Indicator | NAVI | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 42.06 |
| Support Level | $7.86 | $3.03 |
| Resistance Level | $8.82 | $3.43 |
| Average True Range (ATR) | 0.27 | 0.20 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 88.49 | 16.13 |
Price Performance
Historical ComparisonAbout NAVI Navient Corporation
Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.